GLP-1 therapies, or glucagon-like peptide-1 compounds, represent a substantial innovation in how we approach type 2 diabetes . These prescription drugs help imitating the body’s own GLP-1 substance , https://thefairlist.com/story12000373/glp-1-a-revolutionary-advance-in-glucose-management